However, the overexpression of these 11 genes had opposite effects on RFS for the basal versus ER-positive breast tumors and on DMFS for ERBB2/HER2-positive versus ER-positive LN-negative tumors in young women with BC (Supplementary Figure S5e). This evidence concerns the gene ESR1 and breast neoplasm.